DPW
ROIV icon

DiNuzzo Private Wealth’s Roivant Sciences ROIV Stock Holding History

DiNuzzo Private Wealth’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37K Buy
67
+4
+6% +$118 ﹤0.01% 614
2026
Q1 		$1.75K Buy
63
+5
+9% +$128 ﹤0.01% 691
2025
Q4 		$1.26K Buy
58
+27
+87% +$533 ﹤0.01% 808
2025
Q3 		$370 Buy
+31
New +$384 ﹤0.01% 1162

Other funds holding ROIV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CA
Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.2B AUM 13.59% 1-Year Est. Return

DiNuzzo Private Wealth's ROIV Position: Q2 2026 in Review

DiNuzzo Private Wealth increased its Roivant Sciences (ROIV) stake by 6.3% in Q2 2026, buying an estimated $118 and bringing the position to 67 shares worth $2.37K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

DiNuzzo Private Wealth first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 129 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • DiNuzzo Private Wealth held 67 shares of Roivant Sciences worth $2.37K as of Q2 2026.
  • DiNuzzo Private Wealth bought 4 Roivant Sciences shares in Q2 2026, an estimated $118.
  • Roivant Sciences made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #614 holding.
  • DiNuzzo Private Wealth first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 129 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.